Senior Business Development Manager/Associate Business Development Director at Click Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Digital Therapeutics, Healthcare, Biotechnology, PharmaceuticalsIndustries

Requirements

End-to-end deal experience
Strategic and driven individual
Adept at building relationships with external and internal stakeholders to achieve objectives
Skilled hunter (experienced in sourcing and closing deals)

Responsibilities

Build and manage a strong pipeline of deal opportunities that align with the strategic objectives of the company
Lead end-to-end deal processes, including sourcing, cross-functional diligence, structuring terms and driving negotiations
Identify and execute on creative opportunities to expand Click’s partnering presence in the industry
Contribute to broader business development strategy and direction beyond owned therapeutic areas

Skills

Key technologies and capabilities for this role

Business DevelopmentDeal SourcingDeal StructuringNegotiationPipeline ManagementDue DiligenceStrategic PlanningRelationship BuildingPartneringCross-Functional Collaboration

Questions & Answers

Common questions about this position

What is the work location for this position?

The position is hybrid, based in either Tribeca, NYC or Boston, MA.

What is the salary for this role?

This information is not specified in the job description.

What skills or experience are required for this role?

This information is not specified in the job description.

What is the company culture like at Click Therapeutics?

Click Therapeutics fosters an inclusive, diverse workforce and is consistently named a best place to work.

What makes a strong candidate for this business development role?

The ideal candidate has end-to-end deal experience, is strategic and driven, adept at building relationships with stakeholders, and is a skilled hunter.

Click Therapeutics

Develops software as prescription medical treatments

About Click Therapeutics

Click Therapeutics develops software applications that function as prescription medical treatments for patients with various health conditions. These digital therapeutics are designed to change cognitive and neurobehavioral mechanisms related to diseases, and they are tested through rigorous randomized controlled trials to ensure safety and effectiveness. After validation, the company seeks FDA clearance to market these applications as class II medical devices. Unlike traditional pharmaceuticals, Click Therapeutics' products are prescribed by physicians and reimbursed by payers, allowing for a unique revenue model. A notable collaboration with Boehringer Ingelheim aims to create a digital therapeutic for schizophrenia, highlighting the potential of this approach in healthcare. The goal of Click Therapeutics is to provide effective digital solutions for patients with unmet medical needs, continuously improving their applications using real-world evidence.

New York City, New YorkHeadquarters

2012Year Founded

$93.9MTotal Funding

DEBTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Unlimited Paid Time Off

Flexible Work Arrangement

Stock Options

Performance Bonus

Fertility Treatment Support

Professional Development Budget

Commuter Benefits

Risks

Increased competition from digital therapeutic companies may impact market share.

Regulatory changes could affect approval processes for new digital therapeutics.

Integration challenges from acquisitions may delay new product development.

Differentiation

Click Therapeutics specializes in software as medical treatments for unmet medical needs.

Their Clickometrics® platform personalizes user experience to optimize engagement and outcomes.

Partnership with Boehringer Ingelheim highlights their collaborative approach in digital therapeutics.

Upsides

FDA clearance of Rejoyn™ boosts credibility in digital therapeutics for mental health.

Acquisition of Better Therapeutics expands Click's reach into cardiometabolic diseases.

$20 million financing from HSBC supports expansion and development initiatives.

Land your dream remote job 3x faster with AI

Try Jobo Free